1. Home
  2. ALAR vs NVNO Comparison

ALAR vs NVNO Comparison

Compare ALAR & NVNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alarum Technologies Ltd.

ALAR

Alarum Technologies Ltd.

HOLD

Current Price

$7.80

Market Cap

57.1M

Sector

Technology

ML Signal

HOLD

Logo enVVeno Medical Corporation

NVNO

enVVeno Medical Corporation

HOLD

Current Price

$0.33

Market Cap

16.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ALAR
NVNO
Founded
2013
1987
Country
Israel
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
57.1M
16.7M
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
ALAR
NVNO
Price
$7.80
$0.33
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$27.00
N/A
AVG Volume (30 Days)
82.2K
440.2K
Earning Date
11-26-2025
10-31-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.02
N/A
Revenue
$36,305,000.00
N/A
Revenue This Year
$31.17
N/A
Revenue Next Year
$30.14
N/A
P/E Ratio
$47.37
N/A
Revenue Growth
15.03
N/A
52 Week Low
$5.45
$0.30
52 Week High
$18.00
$5.62

Technical Indicators

Market Signals
Indicator
ALAR
NVNO
Relative Strength Index (RSI) 31.06 38.43
Support Level $7.46 $0.32
Resistance Level $7.93 $0.37
Average True Range (ATR) 0.36 0.03
MACD 0.24 0.01
Stochastic Oscillator 54.55 40.75

Price Performance

Historical Comparison
ALAR
NVNO

About ALAR Alarum Technologies Ltd.

Alarum Technologies Ltd is a software-as-a-service (SaaS) provider operating mainly in the web data collection market, offering web data collection and a private internet browsing platform. The company's Web Data Collection products offer secure, fast, and anonymous IP Proxy Network Solutions & Services, or IPPN or IPPN Solutions, to its business customers which, in turn, enables them to anonymously and securely browse the internet as well as to collect data from any publicly available source on the web, for their business purpose. The company operates in one segment, which is web data collection. Geographically, it derives maximum revenue from United Arab Emirates, followed by China, the United States, Europe, Asia-Pacific, U.K. Virgin Islands, Middle East and Africa, and other regions.

About NVNO enVVeno Medical Corporation

enVVeno Medical Corp is a late clinical-stage medical device company focused on advancing bioprosthetic (tissue-based) solutions to improve the standard of care for treating venous disease. The company's product, VenoValve, is a surgical replacement venous valve that is currently being evaluated in a U.S. pivotal study. The company is also developing a second product called enVVe, which is a non-surgical, transcatheter-based replacement venous valve. Both the products are designed to act as one-way valves to help assist in propelling blood up the veins of the leg, and back to the heart and lungs. The company has determined that it currently operates in a single segment, Medical Device development, located in a single geographic location, the United States.

Share on Social Networks: